Bluejay Diagnostics Inc (BJDX)

$1.79 +0.03 (1.70%)
Market Cap 1.82M
Revenue (ttm) 0.00
Net Income (ttm) -6.85M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 114,700
Avg Vol 72,494
Day's Range N/A - N/A
Shares Out 1.04M
Stochastic %K 24%
Beta 0.72
Analysts Strong Buy
Price Target $32.00

Company Profile

Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests fo...

Industry: Medical Devices
Sector: Healthcare
Phone: 844 327 7078
Address:
360 Massachusetts Avenue, Suite 203, Acton, United States
QuantumTechnology
QuantumTechnology May. 12 at 6:41 PM
$BJDX Accumulating my base position. They need to dilute, but dilution requires volume. Expecting a 50-100% liquidity spike soon.
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser May. 11 at 6:50 PM
$BJDX RSI: 38.49, MACD: -0.0509 Vol: 0.08, MA20: 1.89, MA50: 1.92 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Jj1369
Jj1369 May. 11 at 3:26 PM
$BJDX BEARISH RIP to this scam!
0 · Reply
Jj1369
Jj1369 May. 11 at 1:44 PM
$BJDX NOT GOING TO SEE $2.00 UNTIL THE NEXT RS SO BEARISH COMPLETE SCAM COMPANY
0 · Reply
Jj1369
Jj1369 May. 8 at 8:00 PM
$BJDX LOWEST ALL TIME CLOSING PRICE ON DAILY AND WEEKLY!!! GOING TO FUCKING ZERO! SHORT THIS TRASH!!!
0 · Reply
Jj1369
Jj1369 May. 8 at 3:26 PM
$BJDX RIP to this scam! CEO is a complete fraud! Company is a worthless shell that will never have a product! They exist to steal capital for insiders! SCAM STOCK
0 · Reply
Jj1369
Jj1369 May. 7 at 5:02 PM
$BJDX REVERSE SPLIT COMING OFFERING COMING GOING TO ZERO!!!!
0 · Reply
Jj1369
Jj1369 May. 6 at 9:26 PM
$BJDX offering imminent. Going to pennyland! BJDX IS A SCAM
0 · Reply
StockDocOne
StockDocOne May. 6 at 3:00 PM
$BJDX target $7. Don’t know if I will hang that long to see it but expecting a pop soon. The 20 day is grinding on the 50 day. Something has to give way soon. Up or down.
1 · Reply
StockDocOne
StockDocOne May. 6 at 11:37 AM
$BJDX let’s go any day now.
0 · Reply
Latest News on BJDX
Bluejay Diagnostics Provides First Quarter 2026 Corporate Update

May 7, 2026, 4:01 PM EDT - 5 days ago

Bluejay Diagnostics Provides First Quarter 2026 Corporate Update

Bluejay Diagnostics reaches 624 patient enrollment in Symphony clinical trial

2026-04-07T10:45:34.000Z - 5 weeks ago

Bluejay Diagnostics reaches 624 patient enrollment in Symphony clinical trial

Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial

Apr 7, 2026, 6:30 AM EDT - 5 weeks ago

Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial

Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Mar 12, 2026, 6:30 AM EDT - 2 months ago

Bluejay Announces Abstract Accepted for Presentation at the 2026 Society of Academic Emergency Medicine (SAEM) Annual Meeting

NorthStrive Fund urges Bluejay to evaluate strategic opportunity

2026-03-11T13:35:11.000Z - 2 months ago

NorthStrive Fund urges Bluejay to evaluate strategic opportunity

NorthStrive Fund II LP Issues Open Letter to the Board and Shareholders of Bluejay Diagnostics

Mar 11, 2026, 9:29 AM EDT - 2 months ago

NorthStrive Fund II LP Issues Open Letter to the Board and Shareholders of Bluejay Diagnostics

Bluejay Diagnostics says SYMON II study ‘progressing as planned’

2026-03-06T11:41:51.000Z - 2 months ago

Bluejay Diagnostics says SYMON II study ‘progressing as planned’

Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised

Feb 20, 2026, 6:30 AM EST - 2 months ago

Bluejay Diagnostics Announces All Prefunded Warrants Now Exercised

Bluejay Diagnostics enrolls 545 patients in SYMON II study

2026-02-17T11:45:15.000Z - 3 months ago

Bluejay Diagnostics enrolls 545 patients in SYMON II study

Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026

Feb 17, 2026, 6:30 AM EST - 3 months ago

Bluejay Diagnostics Successfully Enrolls 545 Patients in SYMON™ II Study and Advances Manufacturing Readiness into 2026

Bluejay Diagnostics Inc trading halted, news pending

2026-01-29T00:50:10.000Z - 3 months ago

Bluejay Diagnostics Inc trading halted, news pending

Bluejay Diagnostics announces 1-for-4 reverse stock split

2026-01-27T13:10:41.000Z - 3 months ago

Bluejay Diagnostics announces 1-for-4 reverse stock split

Bluejay Diagnostics completes commercial-scale IL-6 antibody production

2025-12-29T12:05:14.000Z - 4 months ago

Bluejay Diagnostics completes commercial-scale IL-6 antibody production

Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production

Dec 29, 2025, 7:00 AM EST - 4 months ago

Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production

Bluejay Diagnostics provides Q3 corporate update

2025-11-10T12:55:58.000Z - 6 months ago

Bluejay Diagnostics provides Q3 corporate update

Bluejay Diagnostics files to sell 6.93M shares of common stock for holders

2025-10-23T21:05:24.000Z - 7 months ago

Bluejay Diagnostics files to sell 6.93M shares of common stock for holders

Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Oct 10, 2025, 5:16 PM EDT - 7 months ago

Bluejay Diagnostics Announces Closing of $4.5 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Bluejay Diagnostics announces $4.5M private placement priced at-the-market

2025-10-09T19:20:15.000Z - 7 months ago

Bluejay Diagnostics announces $4.5M private placement priced at-the-market

Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Oct 9, 2025, 3:15 PM EDT - 7 months ago

Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

Why Is Bluejay Diagnostics Stock (BJDX) Up 115% Today?

2025-10-09T12:11:30.000Z - 7 months ago

Why Is Bluejay Diagnostics Stock (BJDX) Up 115% Today?

Bluejay Diagnostics and SanyoSeiko expand partnership for Symphony platform

2025-10-09T10:35:27.000Z - 7 months ago

Bluejay Diagnostics and SanyoSeiko expand partnership for Symphony platform

Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform

Oct 9, 2025, 6:30 AM EDT - 7 months ago

Bluejay Diagnostics and SanyoSeiko Expand Strategic Partnership to Advance Commercialization of Symphony Platform

Bluejay Diagnostics Provides Second Quarter Business and Corporate Update

Aug 7, 2025, 6:30 PM EDT - 9 months ago

Bluejay Diagnostics Provides Second Quarter Business and Corporate Update

Bluejay Diagnostics provides corporate update, reduces headcount to five

2025-06-03T20:20:12.000Z - 1 year ago

Bluejay Diagnostics provides corporate update, reduces headcount to five

Bluejay Diagnostics Provides Mid-Year Business and Corporate Update

Jun 3, 2025, 4:05 PM EDT - 1 year ago

Bluejay Diagnostics Provides Mid-Year Business and Corporate Update

Bluejay Diagnostics files to sell 1.09M shares of common stock for holders

2025-04-29T21:35:15.000Z - 1 year ago

Bluejay Diagnostics files to sell 1.09M shares of common stock for holders

Bluejay Diagnostics announces abstract acceptance at 2025 SAEM meeting

2025-04-15T11:11:20.000Z - 1 year ago

Bluejay Diagnostics announces abstract acceptance at 2025 SAEM meeting

Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Apr 15, 2025, 7:00 AM EDT - 1 year ago

Bluejay Announces Abstract Accepted for Presentation at the 2025 Society of Academic Emergency Medicine (SAEM) Annual Meeting

Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds

Apr 7, 2025, 5:21 PM EDT - 1 year ago

Bluejay Diagnostics Announces Entry into Warrant Inducement Transaction for Approximately $3.7 Million in Gross Proceeds

Bluejay Diagnostics Inc trading halted, news pending

2024-11-16T00:50:13.000Z - 1 year ago

Bluejay Diagnostics Inc trading halted, news pending

Bluejay Diagnostics announces 1-for-50 reverse stock split

2024-11-13T22:20:26.000Z - 1 year ago

Bluejay Diagnostics announces 1-for-50 reverse stock split

Bluejay Diagnostics Announces Reverse Stock Split

Nov 13, 2024, 5:10 PM EST - 1 year ago

Bluejay Diagnostics Announces Reverse Stock Split

Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering

Jun 28, 2024, 11:32 AM EDT - 2 years ago

Bluejay Diagnostics Announces Closing of $8.75 Million Underwritten Public Offering

Bluejay Diagnostics announces pricing of $8.75M underwritten public offering

2024-06-27T13:01:26.000Z - 2 years ago

Bluejay Diagnostics announces pricing of $8.75M underwritten public offering

SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients

Jun 26, 2024, 8:00 AM EDT - 2 years ago

SYMON-I Study of Symphony IL-6 Suggests Prediction of Mortality in Sepsis Patients

Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering

Jan 2, 2024, 5:58 PM EST - 2 years ago

Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering

Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering

Dec 28, 2023, 8:00 AM EST - 2 years ago

Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering

Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)

Dec 27, 2023, 9:00 AM EST - 2 years ago

Bluejay Diagnostics, Inc. Announces Initiation of Multicenter Clinical Study Evaluating Symphony IL-6 in Sepsis Patients (SYMON Study)

Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

Nov 9, 2023, 4:05 PM EST - 2 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Aug 25, 2023, 8:00 AM EDT - 2 years ago

Bluejay Diagnostics Announces $1.59 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results

Aug 16, 2023, 7:00 AM EDT - 2 years ago

Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results

Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy

May 19, 2023, 7:00 AM EDT - 3 years ago

Bluejay Diagnostics Updates Symphony IL-6 Regulatory Strategy

Bluejay Diagnostics Reports First Quarter 2023 Financial Results

May 10, 2023, 7:30 AM EDT - 3 years ago

Bluejay Diagnostics Reports First Quarter 2023 Financial Results

Bluejay Diagnostics Reports 2022 Financial Results

Mar 20, 2023, 4:15 PM EDT - 3 years ago

Bluejay Diagnostics Reports 2022 Financial Results

Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America

Feb 16, 2023, 8:00 AM EST - 3 years ago

Bluejay Diagnostics Signs Collaboration Agreement with Blood Centers of America

Bluejay Diagnostics, Inc. Reports Third Quarter 2022 Financial Results

Nov 9, 2022, 8:00 AM EST - 3 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2022 Financial Results

Bluejay Diagnostics, Inc. to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Aug 30, 2022, 4:05 PM EDT - 4 years ago

Bluejay Diagnostics, Inc. to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Bluejay Diagnostics, Inc. to Host Key Opinion Leader Event on IL-6 Testing in Critical Care Settings: The Emerging Use of Biomarkers in Contemporary Management of COVID-19/Respiratory Failure

Aug 16, 2022, 7:30 AM EDT - 4 years ago

Bluejay Diagnostics, Inc. to Host Key Opinion Leader Event on IL-6 Testing in Critical Care Settings: The Emerging Use of Biomarkers in Contemporary Management of COVID-19/Respiratory Failure

Positive Clinical Results for Bluejay's Symphony IL-6 Test Presented at AACC 2022

Jul 27, 2022, 7:30 AM EDT - 4 years ago

Positive Clinical Results for Bluejay's Symphony IL-6 Test Presented at AACC 2022

Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results

Jul 26, 2022, 4:30 PM EDT - 4 years ago

Bluejay Diagnostics, Inc. Reports Second Quarter 2022 Financial Results

Bluejay Completes Planned Clinical Studies for Symphony IL-6 Test

Jul 6, 2022, 7:30 AM EDT - 4 years ago

Bluejay Completes Planned Clinical Studies for Symphony IL-6 Test

Bluejay Diagnostics, Inc. Reports First Quarter 2022 Financial Results

Apr 20, 2022, 4:10 PM EDT - 4 years ago

Bluejay Diagnostics, Inc. Reports First Quarter 2022 Financial Results

Bluejay Diagnostics Appoints Edwin Rule as Vice President, Regulatory, Quality and Compliance

Mar 28, 2022, 7:00 AM EDT - 4 years ago

Bluejay Diagnostics Appoints Edwin Rule as Vice President, Regulatory, Quality and Compliance

Bluejay Diagnostics Appoints Kenneth Fisher as Chief Financial Officer

Mar 24, 2022, 7:00 AM EDT - 4 years ago

Bluejay Diagnostics Appoints Kenneth Fisher as Chief Financial Officer

Bluejay Diagnostics, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Mar 10, 2022, 7:00 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

Bluejay Diagnostics, Inc. Announces its Pre-Submission Filing Package for the Symphony IL-6 Test is with the FDA

Jan 31, 2022, 7:00 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Announces its Pre-Submission Filing Package for the Symphony IL-6 Test is with the FDA

Bluejay Diagnostics, Inc. Completes 90 Subjects in Multicenter Clinical Study Addressing Rapid IL-6 Test for COVID-19 Patients in Critical Care

Jan 13, 2022, 11:29 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Completes 90 Subjects in Multicenter Clinical Study Addressing Rapid IL-6 Test for COVID-19 Patients in Critical Care

Bluejay Diagnostics, Inc. Appoints Mark Feinberg, M.D. as Chief Medical Advisor

Jan 5, 2022, 8:15 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Appoints Mark Feinberg, M.D. as Chief Medical Advisor

Bluejay Diagnostics, Inc. Reports Third Quarter 2021 Financial Results

Dec 16, 2021, 9:11 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Reports Third Quarter 2021 Financial Results

Bluejay Diagnostics, Inc. Announces Pricing of Upsized $21.6 Million Initial Public Offering

Nov 10, 2021, 8:15 AM EST - 4 years ago

Bluejay Diagnostics, Inc. Announces Pricing of Upsized $21.6 Million Initial Public Offering

QuantumTechnology
QuantumTechnology May. 12 at 6:41 PM
$BJDX Accumulating my base position. They need to dilute, but dilution requires volume. Expecting a 50-100% liquidity spike soon.
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser May. 11 at 6:50 PM
$BJDX RSI: 38.49, MACD: -0.0509 Vol: 0.08, MA20: 1.89, MA50: 1.92 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Jj1369
Jj1369 May. 11 at 3:26 PM
$BJDX BEARISH RIP to this scam!
0 · Reply
Jj1369
Jj1369 May. 11 at 1:44 PM
$BJDX NOT GOING TO SEE $2.00 UNTIL THE NEXT RS SO BEARISH COMPLETE SCAM COMPANY
0 · Reply
Jj1369
Jj1369 May. 8 at 8:00 PM
$BJDX LOWEST ALL TIME CLOSING PRICE ON DAILY AND WEEKLY!!! GOING TO FUCKING ZERO! SHORT THIS TRASH!!!
0 · Reply
Jj1369
Jj1369 May. 8 at 3:26 PM
$BJDX RIP to this scam! CEO is a complete fraud! Company is a worthless shell that will never have a product! They exist to steal capital for insiders! SCAM STOCK
0 · Reply
Jj1369
Jj1369 May. 7 at 5:02 PM
$BJDX REVERSE SPLIT COMING OFFERING COMING GOING TO ZERO!!!!
0 · Reply
Jj1369
Jj1369 May. 6 at 9:26 PM
$BJDX offering imminent. Going to pennyland! BJDX IS A SCAM
0 · Reply
StockDocOne
StockDocOne May. 6 at 3:00 PM
$BJDX target $7. Don’t know if I will hang that long to see it but expecting a pop soon. The 20 day is grinding on the 50 day. Something has to give way soon. Up or down.
1 · Reply
StockDocOne
StockDocOne May. 6 at 11:37 AM
$BJDX let’s go any day now.
0 · Reply
Jj1369
Jj1369 May. 5 at 7:58 PM
$BJDX NOBODY WANTS THIS SCAM!
0 · Reply
InvestingSpaceman
InvestingSpaceman May. 4 at 9:47 PM
$WTO $KITT $RR $BJDX ADD
0 · Reply
SPACEDAD
SPACEDAD May. 1 at 8:50 PM
$BJDX Popped up on my accumulation scanner. Definitely on watch for a potential break out. Could potentially short squeeze. No position currently.
1 · Reply
Jj1369
Jj1369 May. 1 at 6:27 PM
$BJDX pump and dump scam company! CEO is a fraud! This is going to get dumped! Millions of toxic warrants on the way. Reverse split again by eoy
0 · Reply
StockDocOne
StockDocOne May. 1 at 4:21 PM
$BJDX been waiting patiently to see how this would react when the 20 DMA hit the 50. We are finally here today. Let’s see if it holds.
1 · Reply
Jj1369
Jj1369 Apr. 30 at 8:27 PM
$BJDX
0 · Reply
Jj1369
Jj1369 Apr. 30 at 8:23 PM
$BJDX SHORTING THIS PUMP AND DUMP SCAM
0 · Reply
Jj1369
Jj1369 Apr. 29 at 10:31 PM
$BJDX RIP ☠️☠️
0 · Reply
Jj1369
Jj1369 Apr. 29 at 8:14 PM
$BJDX SHORTING TO zero! COMPANY IS A SHELL CO SCAM EXISTS FOR EXECUTIVES TO GET PAID!!
0 · Reply
Jj1369
Jj1369 Apr. 27 at 8:42 PM
$BJDX going to penny land! Short this trash to nothing!
0 · Reply
Jj1369
Jj1369 Apr. 23 at 7:53 PM
$BJDX millions of toxic warrants coming! This scam is going to $0.50
0 · Reply
Jj1369
Jj1369 Apr. 23 at 6:44 PM
$BJDX another RS coming. Check the latest filing 14A
0 · Reply